Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 August 2021 | Story Ruan Bruwer | Photo Roger Sedres (Gallo Images)
Louzanne Coetzee and her guide Estean Badenhorst won the silver medal in the 1 500 m in a new African time at the Paralympics in Tokyo on Monday.

It’s been eight years of waiting, but Louzanne Coetzee will finally hang a medal around her neck, and this on the biggest sporting stage in the world.

Coetzee won the silver medal in the 1 500 m women’s T11 final at the Paralympics in Tokyo on Monday (30 August 2021) morning. In the process, she and her guide, Estean Badenhorst, set a new African record (4:40.96).

They are both former University of the Free State (UFS) students, and Coetzee is a resident on the Bloemfontein Campus. 

“I have been competing for eight years and this is my first medal. I’m just overwhelmed. I couldn’t have asked for a better race, a better guide, and better preparation. I’m just very thankful for how everything went down,” Coetzee said.
The race took place at 32 degrees with a humidity percentage of 70 plus. Coetzee’s time was only 2.04 seconds off the previous world record. 

She has had a stunning Games so far. In Sunday’s heat, she improved her personal best from 4:51.65 to 4:49.24 and ran another eight seconds quicker on Monday.

It was also a personal triumph for Coetzee, who experienced the disappointment of being disqualified five years ago at the Rio Games, after a ruling that her guide had stepped in front of her. 

Prof Francis Petersen, UFS Rector and Vice-Chancellor, saluted Coetzee. “We are tremendously proud of what she has achieved throughout her athletics career. She has represented the country numerous times at international sport events and winning a silver medal and setting a new African record is the culmination of hard work and exceptional endurance.” 

“The entire university community was rooting for her; she has done us and her country extremely proud,” Prof Petersen said.

Coetzee still has the T12 marathon on Sunday on her schedule.

News Archive

Heart-valve studies receive international recognition
2017-07-11

 Description: Heart-valve studies  Tags: Heart-valve studies  

Prof Francis Smit, Head of the Department of
Cardiothoracic Surgery at the UFS, and Manager of the
Robert WM Frater Cardiovascular Research Centre, with
Kyle Davis, Mechanical Engineer at the centre.

Photo: Rulanzen Martin

Three heart-valve studies which have been developed at the Robert WM Frater Cardiovascular Research Centre at the School of Medicine at the University of the Free State (UFS) were recently presented in Monte Carlo at the conference of the prestigious global Heart Valve Society (HVS).

These studies are all headed by Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS, and Manager of the Robert WM Frater Cardiovascular Research Centre.
Prof Smit says the HVS is a combination of the former heart-valve societies of Europe and the US. “Studies on heart-valve disease, heart-valve-related products and operations, as well as the design and development of new valves were presented. There are both clinical and development divisions.

He says the study in which the hemodynamics of their redesigned mechanical poppet valve was compared to a commercial bi-leaflet mechanical heart valve, was named as the best poster presentation in the experimental valve development and numerical flow dynamics division. The study, which was presented by Kyle Davis, mechanical engineer at the centre, competed against some of the best heart-valve research units in the world.

The redesigned valve, based on the 1960s Cape Town poppet valve, has the potential to provide a low-cost solution for mechanical heart-valve replacement. It is possible to produce the titanium ring with 3-D printers and is, together with the silicon poppet valve, extremely inexpensive compared to current mechanical valve-manufacturing processes.
The advantages of this valve over current mechanical valves is that, due to the effective and laminar flow characteristics, as well as the simple locking mechanisms, there is a reduced chance of valve thrombosis, and the need for anti-clotting drugs is therefore limited.

It was also confirmed that the new valve more than meets the published FDA (Federal Drug Agency) requirements, which determine the minimum standards of valves for human use in the US.

The redesigned valve also has a very low platelet activation impact, which is responsible for platelet thrombosis and leads to valve thrombosis or strokes. This valve is another heart-valve project by the centre, which is also in the process of evaluating a tri-leaflet polyurethane valve developed by them.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept